Addex Therapeutics (ADXN) Net Cash Flow (QoQ) (2019 - 2025)
Addex Therapeutics (ADXN) Net Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Addex Therapeutics |
1.23 Bn |
1.23 Bn |
- |
| Date | Value |
|---|
| Jun 30, 2025 |
208.60% |
| Mar 31, 2025 |
-183.98% |
| Dec 31, 2024 |
110.95% |
| Sep 30, 2024 |
-369.86% |
| Jun 30, 2024 |
196.52% |
| Mar 31, 2024 |
-200.52% |
| Dec 31, 2023 |
183.68% |
| Sep 30, 2023 |
-737.84% |
| Jun 30, 2023 |
30,060,139.60% |
| Mar 31, 2023 |
57.14% |
| Dec 31, 2022 |
-317.20% |
| Sep 30, 2022 |
124.86% |
| Jun 30, 2022 |
-2.95% |
| Mar 31, 2022 |
-207.57% |
| Dec 31, 2021 |
296.43% |
| Sep 30, 2021 |
62.21% |
| Jun 30, 2021 |
-213.82% |
| Mar 31, 2021 |
425.06% |
| Dec 31, 2020 |
144.00% |
| Sep 30, 2020 |
55.97% |
